Amazone Pharmaceuticals Private Limited
About Amazone Pharmaceuticals Private Limited
Data last updated:
Amazone Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2012PTC230027. Its GSTIN is 07AALCA7512R1Z3 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shweta Parekh and Abhishek Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 216 Hall No. 2 Ground Floor Dhakka Village Near Kingsway Camp, Delhi, India – 110009.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.82 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹10.49 Lakh (net margin 3.7%) and EBITDA of ₹29.85 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹57 Lakh and satisfied charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressG – 216 Hall No. 2 Ground Floor Dhakka Village Near Kingsway Camp, Delhi, India – 110009
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Amazone Pharmaceuticals Private Limited
The main business activity of Amazone Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amazone Pharmaceuticals Private Limited FY 2025 filings available
Amazone Pharmaceuticals Private Limited reported revenue of ₹2.82 Cr (up 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Amazone Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 33% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amazone Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹10.49 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amazone Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amazone Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Amazone Pharmaceuticals Private Limited
Amazone Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synaptics Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2024) | •••• | •••• | -36.0% | •••• | Hyderabad, Telangana, India |
| Karad and Patil Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2022) | •••• | •••• | 3274.0% | •••• | Latur, Maharashtra, India |
| Innovinc Healthcare Private Limited | ₹2.82 Cr (FY 2023) | •••• | •••• | -83.0% | •••• | Nagpur, Maharashtra, India |
| Ihl Medicare Private Limited | ₹2.82 Cr (FY 2025) | •••• | •••• | -80.0% | •••• | Mumbai, Maharashtra, India |
| Iatros Pharmaceutical Pvt Ltd | ₹2.82 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Pune, Maharashtra, India |
| Amazone Pharmaceuticals Private Limited this company | ₹2.82 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Renomed Lifesciences Private Limited | ₹2.81 Cr (FY 2024) | •••• | •••• | 193.0% | •••• | Guwahati, Assam, India |
| Meditech Overseas Private Limited | ₹2.81 Cr (FY 2024) | •••• | •••• | 59.0% | •••• | Lucknow, Uttar Pradesh, India |
| Axiom Pharma Private Limited | ₹2.81 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Jaipur, Rajasthan, India |
| Benedic Pharmaceuticals Private Limited | ₹2.81 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Haridwar, Uttarakhand, India |
| Wel-Come Remedies Private Limited | ₹2.81 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Solan, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Amazone Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amazone Pharmaceuticals Private Limited
Amazone Pharmaceuticals Private Limited is audited by A KAY MEHRA & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A KAY MEHRA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Amazone Pharmaceuticals Private Limited
Amazone Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Parekh | Director | 16 Jan 2012 | 14 Years 8 Months | Current |
| Abhishek Gupta Also directs: Avrohn Pharma (I) Limited, Skintra Lifesciences Private Limited | Additional Director | 28 Apr 2016 | 10 Years 5 Months | Current |
| Abhishek Parekh | Additional Director | 28 Apr 2016 | 10 Years 5 Months | Current |
Ownership and Shareholding of Amazone Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amazone Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2025 | Canara Bank | ₹17 Lakh | Open |
| 16 Sep 2020 | Canara Bank | ₹40 Lakh | Open |
| 10 Aug 2017 | Canara Bank | ₹15 Lakh | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Amazone Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Amazone Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amazone Pharmaceuticals Private Limited
Amazone Pharmaceuticals Private Limited has 4 board changes on record since 2012: 3 appointments and 1 cessation. The latest: Chetna Gupta ceased to be Director on 16 Oct 2024.
Credit Ratings, Litigation & Regulatory Alerts for Amazone Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amazone Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amazone Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amazone Pharmaceuticals Private Limited
Amazone Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AALCA7512R1Z3 | Delhi | Active | 25 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amazone Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amazone Pharmaceuticals Private Limited
Amazone Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2012 (14+ years old) and is registered under CIN U33110DL2012PTC230027.
Amazone Pharmaceuticals reported revenue of ₹2.82 Cr for FY 2025 (up 33% YoY).
Amazone Pharmaceuticals has 3 current directors:
- Shweta Parekh - Director
- Abhishek Gupta - Additional Director
- Abhishek Parekh - Additional Director
Amazone Pharmaceuticals reported a net profit of ₹10.49 Lakh (net margin 3.7%) and EBITDA of ₹29.85 Lakh (EBITDA margin 10.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Amazone Pharmaceuticals is 14% over three years and 11% over five years. In the latest year (FY 2025) revenue rose 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Amazone Pharmaceuticals is 07AALCA7512R1Z3, registered in Delhi.
The CIN (Corporate Identification Number) of Amazone Pharmaceuticals is U33110DL2012PTC230027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amazone Pharmaceuticals was incorporated on 16 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Amazone Pharmaceuticals by revenue are Synaptics Pharmaceuticals Private Limited, Karad and Patil Pharmaceuticals Private Limited, Innovinc Healthcare Private Limited, Ihl Medicare Private Limited, Iatros Pharmaceutical Pvt Ltd and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Chetna Gupta ceased to be Director on 16 Oct 2024. Abhishek Gupta was appointed as Additional Director on 28 Apr 2016. Abhishek Parekh was appointed as Additional Director on 28 Apr 2016. Amazone Pharmaceuticals has 4 board changes on record in total.
The registered office of Amazone Pharmaceuticals is at G – 216 Hall No. 2 Ground Floor Dhakka Village Near Kingsway Camp, Delhi, India – 110009.